Alembic Pharmaceuticals rises on getting USFDA’s final nod for Doxycycline Hyclate Delayed release tablets
Alembic Pharmaceuticals is currently trading at Rs. 812.00, up by 2.40 points or 0.30% from its previous closing of Rs. 809.60 on the BSE. The scrip opened at Rs. 807.00 and has touched a high and low of Rs. 814.00 and Rs. 802.00 respectively. So far 8400 shares were traded on the counter. The BSE … Read more